MDL Sought for L’Oreal Class Action Lawsuits Over CeraVe, Other Benzoyl Peroxide Products Contaminated With Cancer-Causing Chemicals
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Researchers Urge FDA To Recall Additional Sunscreens Over Potential Carcinogens August 10, 2021 Russell Maas Add Your Comments According to a recent petition filed with the FDA, a massive sunscreen recall issued last month by Johnson & Johnson, after discovering cancer-causing chemicals in certain aerosol spray products, may actually be related to the active ingredient octocrylene used in a wide variety of different products. A group of scientists from the non-profit research organization, Haereticus Environmental Laboratory (HEL) announced this week that they have filed two petitions asking the U.S. Food and Drug Administration (FDA) to recall thousands of spray-on sunscreen products, including popular brands such as Coppertone, Banana Boat and Neutrogena. The petitions follow a study published in the medical journal Chemical Research in Toxicology in March 2021, which pointed at the use of octocrylene as the cause of benzene contamination in sunscreen products. Did You Know? Benzene has contaminated sunscreens, deodorants and other widely used products Stay up-to-date about developments in benzene lawsuits over the presence of the harmful chemical in a spray sunscreens, deodorants and other products by subscribing to the AboutLawsuits Weekly Digest. "*" indicates required fields Email* Δ Learn More Did You Know? Benzene has contaminated sunscreens, deodorants and other widely used products Stay up-to-date about developments in benzene lawsuits over the presence of the harmful chemical in a spray sunscreens, deodorants and other products by subscribing to the AboutLawsuits Weekly Digest. "*" indicates required fields Email* Δ Learn More The group of researchers, led by Craig Downs, executive director of the HEL, worked with researchers at the Paris-based Sorbonne University and tested 16 octocrylene-based sunscreens intended for adults and infants for sale in the U.S. and France, including Beiersdorf AG’s Coppertone Water Babies spray, Edgewell Personal Care Co.’s Banana Boat SPF 50 lotion and a Neutrogena Beach Defense spray and lotion from Johnson & Johnson. Octocrylene is a common chemical sunscreen ingredient that once absorbed into the skin, captures harmful UV rays before they can cause damage to the skin. According to the results of the tests, all of the octocrylene-based sunscreens tested positive for benzophenone, which is an industrial chemical that has been associated with the development of several fatal forms of cancer, leukemia and other conditions, such as AML, Chronic Myelogenous Leukemia (CML), Acute Lymphocytic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL), Hairy Cell Leukemia (HCL), Non-Hodgkin’s Lymphoma, Multiple Myeloma, Myelodysplastic Syndrome (MDL), Myelofibrosis and Myeloid Metaplasia, Aplastic Anemia and Thrombocytopenic Purpura. Downs indicates the degradation of octocrylene is the likely source for benzophenone contamination in an estimated 2,400 sun-protection products, leaving millions of consumers exposed to unlabeled hormone and reproductive organ disrupting chemicals absorbed in to the skin. The petitions filed by Downs specifically calls on the FDA to remove all sunscreens containing octocrylene from the market until they can be deemed safe. Long-term side effects of benzene exposure have been proven to cause anemia, which is a condition that develops when your blood lacks enough healthy red blood cells or hemoglobin. Essentially, the chemical causes bone marrow not to produce enough red blood cells, which can damage an individual’s immune system. Federal regulators have determined long-term exposure to benzene can significantly impact blood cells, to the extent it causes cancer such as leukemia, which affects the blood-forming organs. In May, the on-line pharmacy Valisure issued a press release warning that benzene was detected in 78 sunscreen and after-sun care products, with more than a quarter of products exceeding 2 parts per million (ppm); the level at which the FDA considers benzene in the products to be a concern. Last month, the FDA announced a Johnson & Johnson Neutrogena and Aveeno sunscreen recall after routine sample testing identified levels of benzene which exceeded the agency’s standards. Johnson & Johnson subsequently announced that benzene is not an intended ingredient for any brand of their sunscreen products, and the company will continue to work with the FDA to determine how the chemical was introduced into the recalled aerosol sunscreen spray cans. As a result of the recall, Johnson & Johnson faces a growing number of sunscreen class action lawsuits for marketing their sunscreens as a way to decrease the risk of skin cancer, without disclosing that the aerosol spray cans contain dangerous levels of a known carcinogen. Tags: Aveeno, Benzene, Cancer, Coppertone, Neutrogena, Sunscreen, Sunscreen Recall Image Credit: Image via <a href="http://www.flickr.com/photos/booleansplit/">booleansplit</a> via <a href="http://creativecommons.org/licenses/by/2.0/" target="_blank" rel="noopener">Flickr CC by 2.0</a> More Sunscreen Recall Lawsuit Stories JPML Refuses To Consolidate Lawsuits Over Benzene in L’Oreal CeraVe, Other Acne Products February 14, 2025 MDL Sought for L’Oreal Class Action Lawsuits Over CeraVe, Other Benzoyl Peroxide Products Contaminated With Cancer-Causing Chemicals January 3, 2025 Manufacturer to Remove Benzene-Linked Chemical from Generic Mucinex Due to Cancer Concerns August 23, 2024 1 Comments Joe August 11, 2021 FYI … industry responded to our research with … “The European Union has approved octocrylene for use in sunscreens.” With respect to European Union SCCS toxicity testing, octocrylene is normally used in products (UV-filters/sunscreens and anti-aging products) that contain water and when octocrylene is exposed to water it breaks-down into the carcinogen BENZOPHENONE (BP) via retro-aldol condensation. This reaction starts immediately upon exposure to water and continues to occur over-time causing BP to increase in concentration as the product ages. Almost all of the toxicology studies in the SCCS opinion (acute toxicity, sub-chronic toxicity, repeated dose toxicity, reproductive toxicity … etc.) that were used to determined that octocrylene “IS SAFE” is inappropriate because the chemical was tested in anhydrous vehicles which would inhibit BP formation, therefore, the data reported by SCCS “DOES NOT” reflect real-life human exposure to octocrylene/BP and cannot be used to predict human or environmental health risks. Joe DiNardo Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: today) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025) Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025) Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)
JPML Refuses To Consolidate Lawsuits Over Benzene in L’Oreal CeraVe, Other Acne Products February 14, 2025
MDL Sought for L’Oreal Class Action Lawsuits Over CeraVe, Other Benzoyl Peroxide Products Contaminated With Cancer-Causing Chemicals January 3, 2025
Manufacturer to Remove Benzene-Linked Chemical from Generic Mucinex Due to Cancer Concerns August 23, 2024
Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: today) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)
Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)
Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)